An open-label, phase II study of matured dendritic cells pulsed ex vivo with 3 melanoma cell line lysates (IDD-3) with or without peginterferon alpha-2b (PegIFN-a 2b) in patients with resected stage II or III melanoma
100 项与 Immuno-Designed Molecules SA 相关的临床结果
0 项与 Immuno-Designed Molecules SA 相关的专利(医药)
100 项与 Immuno-Designed Molecules SA 相关的药物交易
100 项与 Immuno-Designed Molecules SA 相关的转化医学